PRM34 - Cost –Effectiveness of Obinutuzumab As Frontline Treatment For Unfit Patients With Chronic Lymphocytic Leukemia In Republic of Macedonia.
Autor: | Kapedanovska Nestorovska, A1, Sterjev, Z1, Naumovska, Z1, Grozdanova, A1, Dimovski, A1, Suturkova, L1 |
---|---|
Zdroj: | Value in Health. Oct2017, Vol. 20 Issue 9, pA736-A736. 1p. |
Databáze: | Academic Search Ultimate |
Externí odkaz: |